CN106579460A - Special clinical nutrition formula for fracture and preparation method thereof - Google Patents
Special clinical nutrition formula for fracture and preparation method thereof Download PDFInfo
- Publication number
- CN106579460A CN106579460A CN201611206868.2A CN201611206868A CN106579460A CN 106579460 A CN106579460 A CN 106579460A CN 201611206868 A CN201611206868 A CN 201611206868A CN 106579460 A CN106579460 A CN 106579460A
- Authority
- CN
- China
- Prior art keywords
- fracture
- powder
- clinical nutrition
- fat
- nutrition formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 47
- 230000035764 nutrition Effects 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 116
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 36
- 239000011782 vitamin Substances 0.000 claims abstract description 32
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 30
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- 235000013305 food Nutrition 0.000 claims abstract description 27
- 241000196324 Embryophyta Species 0.000 claims abstract description 23
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 229940088594 vitamin Drugs 0.000 claims abstract description 22
- 229930003231 vitamin Natural products 0.000 claims abstract description 22
- 235000013343 vitamin Nutrition 0.000 claims abstract description 22
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 15
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 15
- 239000011573 trace mineral Substances 0.000 claims abstract description 15
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 15
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 10
- 239000003094 microcapsule Substances 0.000 claims abstract description 9
- 238000004108 freeze drying Methods 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 239000000203 mixture Substances 0.000 claims description 39
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 31
- 239000011575 calcium Substances 0.000 claims description 31
- 229910052791 calcium Inorganic materials 0.000 claims description 31
- 235000008216 herbs Nutrition 0.000 claims description 29
- 230000010354 integration Effects 0.000 claims description 29
- 235000018102 proteins Nutrition 0.000 claims description 28
- 235000013350 formula milk Nutrition 0.000 claims description 26
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 26
- 235000012054 meals Nutrition 0.000 claims description 25
- 235000019197 fats Nutrition 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 235000010469 Glycine max Nutrition 0.000 claims description 17
- 244000068988 Glycine max Species 0.000 claims description 17
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 14
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 14
- 235000010755 mineral Nutrition 0.000 claims description 14
- 239000011707 mineral Substances 0.000 claims description 14
- 241000251468 Actinopterygii Species 0.000 claims description 12
- 229920001661 Chitosan Polymers 0.000 claims description 12
- 108010038807 Oligopeptides Proteins 0.000 claims description 12
- 102000015636 Oligopeptides Human genes 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 10
- 235000014633 carbohydrates Nutrition 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 4
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 3
- 235000013601 eggs Nutrition 0.000 claims description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 241000208688 Eucommia Species 0.000 claims description 2
- 229920001503 Glucan Polymers 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- 244000179886 Moringa oleifera Species 0.000 claims description 2
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 2
- 108010001441 Phosphopeptides Proteins 0.000 claims description 2
- 241000382353 Pupa Species 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- 229940071162 caseinate Drugs 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 235000020243 first infant milk formula Nutrition 0.000 claims description 2
- 229930003944 flavone Natural products 0.000 claims description 2
- 150000002212 flavone derivatives Chemical class 0.000 claims description 2
- 235000011949 flavones Nutrition 0.000 claims description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 235000002710 Ilex cornuta Nutrition 0.000 claims 1
- 241001310146 Ilex cornuta Species 0.000 claims 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims 1
- 241000209140 Triticum Species 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 235000002378 plant sterols Nutrition 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 210000004885 white matter Anatomy 0.000 claims 1
- 208000010392 Bone Fractures Diseases 0.000 abstract description 45
- 206010017076 Fracture Diseases 0.000 abstract description 44
- 230000000694 effects Effects 0.000 abstract description 19
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 16
- 210000000988 bone and bone Anatomy 0.000 abstract description 16
- 239000002994 raw material Substances 0.000 abstract description 16
- 208000015181 infectious disease Diseases 0.000 abstract description 14
- 230000037182 bone density Effects 0.000 abstract description 7
- 235000015097 nutrients Nutrition 0.000 abstract description 7
- 230000029087 digestion Effects 0.000 abstract description 5
- 230000035876 healing Effects 0.000 abstract description 5
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 235000004879 dioscorea Nutrition 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract 2
- 230000000378 dietary effect Effects 0.000 abstract 2
- 239000000686 essence Substances 0.000 abstract 2
- 241000304531 Allium macrostemon Species 0.000 abstract 1
- 241001672694 Citrus reticulata Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000246386 Mentha pulegium Species 0.000 abstract 1
- 235000016257 Mentha pulegium Nutrition 0.000 abstract 1
- 235000004357 Mentha x piperita Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 235000001050 hortel pimenta Nutrition 0.000 abstract 1
- 229960005069 calcium Drugs 0.000 description 30
- 239000000839 emulsion Substances 0.000 description 25
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 16
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 16
- -1 Oleum Camelliae Substances 0.000 description 14
- 229930003270 Vitamin B Natural products 0.000 description 14
- 235000019156 vitamin B Nutrition 0.000 description 14
- 239000011720 vitamin B Substances 0.000 description 14
- 239000005913 Maltodextrin Substances 0.000 description 13
- 229920002774 Maltodextrin Polymers 0.000 description 13
- 229940035034 maltodextrin Drugs 0.000 description 13
- 238000010521 absorption reaction Methods 0.000 description 11
- 235000019688 fish Nutrition 0.000 description 11
- 210000002997 osteoclast Anatomy 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 150000003722 vitamin derivatives Chemical class 0.000 description 10
- 241000283690 Bos taurus Species 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 239000004006 olive oil Substances 0.000 description 9
- 235000008390 olive oil Nutrition 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 239000011715 vitamin B12 Substances 0.000 description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 8
- 229920000858 Cyclodextrin Polymers 0.000 description 8
- 229920001353 Dextrin Polymers 0.000 description 8
- 239000004375 Dextrin Substances 0.000 description 8
- 229920001202 Inulin Polymers 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 8
- 108090000942 Lactalbumin Proteins 0.000 description 8
- 102000004407 Lactalbumin Human genes 0.000 description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 8
- 235000004347 Perilla Nutrition 0.000 description 8
- 244000124853 Perilla frutescens Species 0.000 description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 8
- 229920000294 Resistant starch Polymers 0.000 description 8
- 108010073771 Soybean Proteins Proteins 0.000 description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 8
- 229930003427 Vitamin E Natural products 0.000 description 8
- 206010052428 Wound Diseases 0.000 description 8
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 8
- 235000013734 beta-carotene Nutrition 0.000 description 8
- 239000011648 beta-carotene Substances 0.000 description 8
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 8
- 229960002747 betacarotene Drugs 0.000 description 8
- 210000003022 colostrum Anatomy 0.000 description 8
- 235000019425 dextrin Nutrition 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 229960000304 folic acid Drugs 0.000 description 8
- 235000019152 folic acid Nutrition 0.000 description 8
- 239000011724 folic acid Substances 0.000 description 8
- 229930182830 galactose Natural products 0.000 description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 8
- 150000004676 glycans Chemical class 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 229940029339 inulin Drugs 0.000 description 8
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 8
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 8
- 229940057917 medium chain triglycerides Drugs 0.000 description 8
- 229960003512 nicotinic acid Drugs 0.000 description 8
- 235000001968 nicotinic acid Nutrition 0.000 description 8
- 239000011664 nicotinic acid Substances 0.000 description 8
- 229940055726 pantothenic acid Drugs 0.000 description 8
- 235000019161 pantothenic acid Nutrition 0.000 description 8
- 239000011713 pantothenic acid Substances 0.000 description 8
- 229910052698 phosphorus Inorganic materials 0.000 description 8
- 239000011574 phosphorus Substances 0.000 description 8
- 235000021254 resistant starch Nutrition 0.000 description 8
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 8
- 239000003549 soybean oil Substances 0.000 description 8
- 235000012424 soybean oil Nutrition 0.000 description 8
- 235000019710 soybean protein Nutrition 0.000 description 8
- 229960003080 taurine Drugs 0.000 description 8
- 235000019155 vitamin A Nutrition 0.000 description 8
- 239000011719 vitamin A Substances 0.000 description 8
- 239000011716 vitamin B2 Substances 0.000 description 8
- 235000019165 vitamin E Nutrition 0.000 description 8
- 239000011709 vitamin E Substances 0.000 description 8
- 229940046009 vitamin E Drugs 0.000 description 8
- 229940045997 vitamin a Drugs 0.000 description 8
- 235000008939 whole milk Nutrition 0.000 description 8
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 7
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 7
- 229910001424 calcium ion Inorganic materials 0.000 description 7
- 235000013351 cheese Nutrition 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000011630 iodine Substances 0.000 description 7
- 229910052740 iodine Inorganic materials 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 229910052749 magnesium Inorganic materials 0.000 description 7
- 229940091250 magnesium supplement Drugs 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229960003975 potassium Drugs 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 6
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 6
- 229940052490 naringin Drugs 0.000 description 6
- 229930019673 naringin Natural products 0.000 description 6
- 210000000582 semen Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 229930003316 Vitamin D Natural products 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000001804 emulsifying effect Effects 0.000 description 5
- 238000009940 knitting Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000000050 nutritive effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 235000019166 vitamin D Nutrition 0.000 description 5
- 239000011710 vitamin D Substances 0.000 description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 description 5
- 229940046008 vitamin d Drugs 0.000 description 5
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 235000009854 Cucurbita moschata Nutrition 0.000 description 4
- 240000001980 Cucurbita pepo Species 0.000 description 4
- 235000009852 Cucurbita pepo Nutrition 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000000963 osteoblast Anatomy 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 210000003455 parietal bone Anatomy 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 235000020354 squash Nutrition 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 208000006386 Bone Resorption Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000007591 Tartrate-Resistant Acid Phosphatase Human genes 0.000 description 3
- 108010032050 Tartrate-Resistant Acid Phosphatase Proteins 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 230000024279 bone resorption Effects 0.000 description 3
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 3
- 239000001354 calcium citrate Substances 0.000 description 3
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 235000013337 tricalcium citrate Nutrition 0.000 description 3
- 239000011647 vitamin D3 Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 102000014128 RANK Ligand Human genes 0.000 description 2
- 108010025832 RANK Ligand Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910052756 noble gas Inorganic materials 0.000 description 2
- 150000002835 noble gases Chemical class 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940041022 streptomycins Drugs 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 206010013183 Dislocation of vertebra Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101001018064 Homo sapiens Lysosomal-trafficking regulator Proteins 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-Valine Natural products CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- NFKMFHWPFKCYLX-UHFFFAOYSA-N Longanone Natural products C12=CC=C(OC)C(O)=C2C23CC(=O)C(OC)C4(OC)OC1CC24N(C)CC3 NFKMFHWPFKCYLX-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 102100033472 Lysosomal-trafficking regulator Human genes 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 244000038561 Modiola caroliniana Species 0.000 description 1
- 235000010703 Modiola caroliniana Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 102000004067 Osteocalcin Human genes 0.000 description 1
- 108090000573 Osteocalcin Proteins 0.000 description 1
- 102000004264 Osteopontin Human genes 0.000 description 1
- 108010081689 Osteopontin Proteins 0.000 description 1
- 102000008108 Osteoprotegerin Human genes 0.000 description 1
- 108010035042 Osteoprotegerin Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000173166 Pyrus ussuriensis Species 0.000 description 1
- 235000011572 Pyrus ussuriensis Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229940055042 chromic sulfate Drugs 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 229910000356 chromium(III) sulfate Inorganic materials 0.000 description 1
- 239000011696 chromium(III) sulphate Substances 0.000 description 1
- 235000015217 chromium(III) sulphate Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- AIMMVWOEOZMVMS-UHFFFAOYSA-N cyclopropanecarboxamide Chemical compound NC(=O)C1CC1 AIMMVWOEOZMVMS-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 150000004780 naphthols Chemical class 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 239000003900 neurotrophic factor Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 230000004072 osteoblast differentiation Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a special clinical nutrition formula for fracture and a preparation method thereof. The special clinical nutrition formula for fracture is prepared from the following raw materials: protein, fat, carbohydrate, dietary fiber, macroelements, trace elements, fat-soluble vitamins, water-soluble vitamins, dietary essences, medicinal and edible components, natural plant compounds and new-resource foods; and the medicinal and edible components are at least one component selected from the following: peppermint, dried citrus reticulata peel, Chinese yams, long-stamen onion bulbs, Chinese wolfberry fruits, Chinese date fruits, longan flesh, and orange peel. The components are prepared into powder in advance, wherein the fat is prepared into fat powder by adopting a micro-capsule embedding technology and the dietary essences are prepared into powder by adopting a freeze-drying technology. The components are accordingly screened and proportioned, so that the special clinical nutrition formula disclosed by the invention is capable of providing complete basic energies and nutrients to the patients with fracture; moreover, components capable of increasing bone density, resisting infection, nourishing the blood and conditioning digestion are added, so that the special clinical nutrition formula is conducive to promoting bone healing, enhancing physical fitness and improving treatment effects on the patients with fracture.
Description
Technical field
The present invention relates to special medicine purposes formula food field, and in particular to a kind of fracture tailored version clinical nutrition formula
And preparation method thereof.
Background technology
Fracture is that the seriality of bone structure ruptures wholly or in part.Jing is appropriately processed in time, and most patients can recover former
The function of coming, a few patients can leave different degrees of sequela.Often there is soft tissue injury, bleeds profusely, acutely in patient
Pain or or even concurrently visceral injury etc..Fracture has a large amount of internal hemorrhages, and during absorption of hematoma, body temperature is slightly raised, but is not typically surpassed
38 DEG C are crossed, some there is also the possibility of infection.
Clinically, the fixation of bone is the key link of fractures.Early in 1958, interior fixed EASD just established
The Therapeutic Principle of " blood supply, early functional exercise are protected in anatomical reduction, strong fixation ".Traditional operation is taken mainly at present
It is fixed, partly fixed using Minimally Invasive Surgery.Through treatment, patient can obtain good therapeutic effect substantially.
The method of the promotion union of fracture commonly used after operative treatment at present is to take Chinese medicine preparation.Chinese patent
CN103463380A discloses a kind of Chinese medicine preparation for treating fracture, and its raw material is the Radix Angelicae Dahuricae, Rhizoma Paridis, Herba Calami tetradactyli, Rhizoma Chuanxiong, wall scroll
16 kinds of Chinese herbal medicine such as grass, Herba Jasmini laurifolii, Nidus Vespae, silk cotton, can help the new bone of sequestrum absorption nutrition generation of fracturing, promote wound to heal
Close, 96.7% is up to the total effective rate of fracture patient;Chinese patent CN102198272A disclose it is a kind of promote union of fracture,
The pharmaceutical composition of injured nerve is repaired, its raw material is nerve growth factor, neurotrophic factor, vitamin B12And antipyretic-antalgic
Anti-inflammatory agent, which has a preferably healing facilitation to fracture patient, and trophic nerve unit and can promote repairing for injured nerve
It is multiple.
But, prior art using Chinese medicine preparation treatment fracture method do not consider fracture and operative treatment to patient with
The significant biophysical trauma for coming and nutrition equalization problem over the course for the treatment of.General fracture patient return to one's perfect health needs compared with
Long process, this is easily caused patient and often worries that fracture recovers bad, produces a series of psychological problems, and further result in appetite side
The impact in face.Reduce plus activity, enterokinesia slows down, absorb and be deteriorated, in turn result in Post operation tissue repair healing ability low
Under, cause infection of incisional wound and poor healing, affect the effect for the treatment of.
It is and effect of the nutrition in vital movement is most important, particularly important to patient.In recent years, nutrition is controlled in disease
Effect in treatment is taken seriously year by year, and nutritional intervention disease has become the common recognition of disease treatment.For this purpose, for fracture to patient
Face how to promote knitting, prevent infection of incisional wound, lose blood, the key factor such as digestive problems, develop science, comprehensively clinical
Nutrient formulation, to improving therapeutic effect, accelerates patient and recovers have important value and meaning.
The content of the invention
It is an object of the invention to overcome defect of the prior art, science, comprehensively is provided for fracture patient first
Clinical nutrition formula, specifically, the present invention provides a kind of fracture tailored version clinical nutrition formula and preparation method thereof, the present invention
Described nutrient formulation is to provide science, comprehensive professional Medical Degree for fracture patient.In the basis energy for providing needed by human body
Amount and nutrient on the basis of, be also directed to patient it is common how to promote knitting, prevent infection of incisional wound, lose blood, digestive problems
Etc. key factor, addition increase bone density, infection, enrich blood, nurse one's health digest integration of edible and medicinal herbs composition, natural plants compound and
New resource food, contributes to knitting, the health invigorating of fracture patient, improves therapeutic effect.
For achieving the above object, the present invention is adopted the following technical scheme that:
On the one hand, the present invention provides a kind of wound, infection, operation and other stress state nutrient formulations, including following weight
The component of amount number:35-45 part protein, 15-25 parts fat, 20-35 part carbohydrates, 5-10 part dietary fibers, 0.6-
1.2 parts of macroelements, 0.01-0.03 part trace element, 0.005-0.02 part fatsoluble vitamiies, 0.08-0.2 part water soluble vitamins
Raw element, 0.1-6 part integration of edible and medicinal herbs compositions, 0.1-1 part natural plants compounds and 0.005-0.2 part new resource foods.
In order to further optimize above-mentioned technical proposal, the technical measures taken by the present invention also include:
Preferably, the protein is selected from lactalbumin powder, soybean protein isolate, whole milk powder, dried whole-egg, newborn ferrum egg
In vain, at least one in cattle colostrumss, aminoacid, protein peptide;
Wherein, the aminoacid is selected from 1B-L-Glutamic Acid, mono- glutamic acid of L, mono- arginine of L, L-Tryptophan, L mono-
At least one in glutamine, taurine, mono- L-Valine of L, L-Isoleucine, mono- leucines of L;The protein peptide is selected from Semen sojae atricolor
Oligopeptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin peptide, calcium caseinate
At least one in peptide;Wherein, the preferred ocean fish oligopeptide powder of the protein peptide, Calcium peptide of casein.
Preferably, the fat includes satisfied fatty acid, polyunsaturated fatty acid, monounsaturated fatty acid, OPO structures
At least one in fat, DHA, EPA, ARA, phospholipid, more specifically safflower oil, walnut oil, Oleum Arachidis hypogaeae semen, soybean oil, Ah
Glycerol, olive oil, Oleum Camelliae, oil and fat of sacha inchi, olive oil, Oleum Cocois, perilla oil, bathypelagic fish oil, cupu oil, Petiolus Trachycarpi oil, Adeps Bovis seu Bubali, milk
At least one in oil, Adeps Sus domestica, Medium-chain Triglycerides, lecithin.
Preferably, during the carbohydrate includes Fructose, crystal sugar, Lactose, maltodextrin, tapioca, resistant starch
At least two.
Preferably, the dietary fiber comprising inulin, Rhizoma amorphophalli powder, oligomeric galactose, oligofructose, oligomeric isomaltose,
At least one in soybean polysaccharide, cyclodextrin, resistant dextrin, soybean fiber.
Preferably, the macroelement is selected from calcium citrate, L-calcium lactate, calcium hydrogen phosphate, potassium gluconate, sodium citrate
With at least one in magnesium gluconate;It is highly preferred that the macroelement at least includes calcium citrate, L-calcium lactate and phosphoric acid
Hydrogen calcium.
Preferably, the trace element is selected from Ferrous gluconate, potassium iodide, zinc gluconate, sodium selenite, glucose
At least one in sour copper, chromic sulfate, manganese gluconate and sodium molybdate.
Preferably, the fatsoluble vitamin is selected from vitamin A, beta-carotene, Vitamin D3, Vitamin E, vitamin
At least one in K1.
Preferably, the water soluble vitamins are selected from vitamin B1, vitamin B2, vitamin B6, Vitamin B12, dimension life
At least one in plain C, pantothenic acid, Folic Acid, nicotinic acid, choline, inositol, biotin.
Preferably, the meals elite is selected from frumentum, beans, potato class, greengrocery, Homonemeae, nut-seed class, fish and shrimp
At least one in class, poultry meat, fruits;Wherein, described frumentum is mainly by rice meal, millet powder, black rice flour, the heart of a lotus seed
One kind or at least two compositions in rice flour, Semen Maydis powder, wheat germ powder, oatmeal, Fagopyrum esculentum Moench powder;The beans is mainly by Semen Pisi sativi
One kind or at least two compositions in powder, Semen phaseoli radiati powder, black bean powder, red bean powder, Semen sojae atricolor powder;The potato class are mainly by common yam rhizome powder group
Into;The Vegetable powder is mainly by Radix Dauci Sativae powder, white radish powder, Fructus Cucurbitae moschatae powder, Herba Spinaciae powder, tomato meal, broccoli powder, Fructus Momordicae charantiae powder, Fructus Cucumidis sativi
One or more compositions in seed powder;The Homonemeae is mainly made up of one or more in mushroom powder and Tremella powder;It is described
Nut-seed class is mainly Semen Nelumbinis powder;The fish and shrimp are mainly made up of one or more in salmon fish powder and cod meal;
The poultry meat is mainly made up of one or more in Carnis Gallus domesticus powder, beef powder;The fruit is mainly by red date powder, Arillus Longan
One or more compositions in powder, apple powder, cherry powder, Citrus powder, pear powder;The meals elite be more preferably oatmeal,
At least one in cucumber seed powder.
Preferably, the integration of edible and medicinal herbs composition is selected from Herba Menthae, Exocarpium Citri Rubrum, Rhizoma Dioscoreae, Bulbus Allii Macrostemonis, Fructus Lycii, Fructus Jujubae, Arillus Longan, Pericarpium Citri tangerinae
In at least one.
Preferably, the natural plants compound is selected from L-carnitine, glucosamine, oligofructose, phylloxanthin, plant
At least one in sterol, lycopene, resveratrol, garlicin;The natural plants compound is more preferably L-carnitine.
Preferably, the new resource food is selected from first milk basic protein, γ-aminobutyric acid, oligochitosan, eucommia Bark male flower, bamboo
At least one in leaf flavone, phosphopeptide caseinate, avenabeta glucosan, yeast beta-dextran, leaf of Moringa, oligomeric xylose;Institute
It is 1 to state new resource food and be more preferably newborn mineral salt and the ratio of weight and number of oligochitosan, the newborn mineral salt and oligochitosan:1.
Preferably, the high quality protein weight provided in the protein and aminoacid accounts for the 70% of gross protein weight
More than.
Preferably, in the fat, the ratio of n-6 fatty acids and n-3 fatty acids is 3~4:1.
Preferably, in the integration of edible and medicinal herbs composition, the parts by weight of each component are as follows:Herba Menthae 0-0.2 parts, Exocarpium Citri Rubrum 0-0.2
Part, Rhizoma Dioscoreae 0-0.25 parts, Bulbus Allii Macrostemonis 0-0.2 parts, Fructus Lycii 0-0.2 parts, Fructus Jujubae 0-0.2 parts, Arillus Longan 0-0.2 parts, Pericarpium Citri tangerinae 0-0.2
Part.
On the other hand, the present invention relates to a kind of product prepared by fracture tailored version clinical nutrition formula, including nutritive powder,
Nutrition emulsion, capsule, tablet, pill, oral liquid etc..
Finally, the present invention also provides a kind of method that the fracture tailored version clinical nutrition formula is prepared into nutritive powder,
Which comprises the steps:By the protein of predetermined weight number, fat, carbohydrate, dietary fiber, macroelement, micro
Element, fatsoluble vitamin, water soluble vitamins, integration of edible and medicinal herbs composition, natural plants compound and new resource food difference
The powdery that particle diameter is 100~300 μm is prepared into, by the powdery mix homogeneously, wound, infection is obtained, is performed the operation and other stress
State nutritive powder, after sterilization processing, fill is in packaging bag or is placed directly within pail pack;Wherein, the fat is adopted
Microcapsule embedding techniqueses make powder, and the meals elite makes powder using freeze drying process, the integration of edible and medicinal herbs into
Divide powder is made by crushing, crossing 60-80 mesh sieves.
The present invention also provides a kind of method that the fracture tailored version clinical nutrition formula is prepared into nutrition emulsion, its bag
Include following steps:
Step one, by the protein of predetermined weight number, fat, carbohydrate, dietary fiber, macroelement, micro
Element, fatsoluble vitamin, water soluble vitamins, integration of edible and medicinal herbs composition, natural plants compound and new resource food difference
It is prepared into the powdery that particle diameter is 100~300 μm;Wherein, the fat makes powder, the meals using microcapsule embedding techniqueses
Elite makes powder using freeze drying process, and the integration of edible and medicinal herbs composition makes powder by crushing, crossing 60-80 mesh sieves
Shape;
Step 2, protein powder is dissolved in in a certain amount of water abundant aquation, obtains protein aqueous solution, then by carbon
Hydrate powder, macroelement powder, trace element powder, water soluble vitamins powder are dissolved in protein aqueous solution,
Gentle agitation is carried out, the aqueous phase solution being uniformly mixed;
Step 3, by the fat powder after microcapsule embedding treatment, fatsoluble vitamin powder, integration of edible and medicinal herbs component powders,
Natural plants compound powder sequentially adds the aqueous phase solution of gained in step 2, and carries out strong agitation, addition emulsifying agent and
Thickening agent, the concentrated emulsions being uniformly mixed;
Step 4, in the concentrated emulsions described in step 3 add scheduled volume water and stir, while removing skim-coat
Foam, obtains Emulsion, then by Emulsion homogenizing under high pressure, in high temperature sterilize, is cooled to room temperature, and nutrition emulsion is obtained, and will
Nutrition emulsion fill is in packaging bag.
In above two preparation method, the specific implementation step of microcapsule embedding techniqueses is as follows:By fat, emulsifying agent, wall
Material prepares emulsion with water mixed dissolution;After by the stirring mixing of above-mentioned emulsion, emulsifying homogeneous process is carried out, is then sprayed
It is dried, screening prepares powdered oil, and powdered oil is compared with conventional grease, its dispersibility, water solublity, emulsibility, non-oxidizability
All improve a lot;
Wherein, the emulsifying agent is selected from fatty acid glyceride (glyceride), methyl glycol fatty acid ester (propylene glycol ester), Pyrusussuriensiss
One or more in polysaccharide fatty acid ester (sorbitan acid), sucrose fatty acid ester (sucrose ester), lecithin;The wall material choosing
From sodium carboxymethyl cellulose, gelatin, carrageenan, xanthan gum, arabic gum, guar gum, maltodextrin, lipoprotein, corn syrup
In one or more.
In above two preparation method, the specific implementation step of freeze drying process is as follows:Raw material is cleaned, and to washing
Raw material after net carries out predrying, then carries out pre-freeze to raw material so as to which pressure is evacuated to vacuum state and carries out sublimation drying, finally
Dried raw material is carried out crushing 80 mesh sieves, the meals elite powder prepared using this technique farthest can be kept
The color, smell and taste of raw material, go moisture removal thoroughly, and product can be preserved for a long time and be never degenerated.
In the present invention using include Herba Menthae, Exocarpium Citri Rubrum, Rhizoma Dioscoreae, Bulbus Allii Macrostemonis, Fructus Lycii, Fructus Jujubae, Arillus Longan, Pericarpium Citri tangerinae integration of edible and medicinal herbs into
Point, by increasing capacitance it is possible to increase the bone density of patient, improves infection composition, while being enriched blood and being nursed one's health digestion.
Herba Menthae can cure cold to generate heat and have sore throat, headache, conjunctival congestion with ophthalmalgia, myalgia, skin rubella itching, the disease such as measles without adequate eruption,
In addition to carbuncle, cellulitis, scabies, tinea, dermatitis rhus also effectively, which contains menthol, the material can fresh breath with various property of medicine, can delay
Solution stomachache, gall-bladder problem such as spasm, also with antisepsis and sterilization, diuresis, resolving sputum, stomach invigorating and it is aid digestion the effects such as;
The chemical composition naringin of Exocarpium Citri Rubrum and Pericarpium Citri tangerinae, not only promoting bone growing but also the broken bone effect of suppression.Naringin is to rat reality
The healing of the property tested bone injury has very strong facilitation, and acts on enhancing with Dose enhancement factors.The bone strengthening effect of naringin, both promoted
Osteoblast activity, mechanism are probably the expression that naringin can improve bone morphogenic protein BMP-2-2;Bone can be suppressed brokenly thin again
Born of the same parents, its mechanism are the RANKL signalling channels for suppressing osteoclast cell activation, cause differentiation of osteoclast, propagation to be obstructed, reduce bone and inhale
Receive, and the bone dissolving of polymethacrylates induction can be suppressed.In terms of bone resorption is reduced, naringin has suppression tartaric acid acid
Acid phosphatase activity, reduces RANKL expression, suppresses osteoclast activity, reduces the effect that the loss and bone density of bone amount decline;
In terms of skeletonization, naringin mainly improves osteopontin, the expression of osteoprotegerin, increases Bone Gla protein, promotes human marrow-interstitial
The ability of stem cell HBMSCs cells propagation and Osteoblast Differentiation.
Rhizoma Dioscoreae enters lung, spleen, kidney channel, spleen reinforcing;Foster lung;Reinforce the kidney;Beneficial essence.Main diarrhea due to hypofunction of the spleen;Lack of appetite edema;Cough and asthma due to lung deficiency;Disappear
Yearningly;Kidney deficiency frequent micturition;Carbuncle is controlled in external;Scrofula.Breath with cough for spleen eating less, incessant chronic diarrhea, the deficiency of the lung, frequent micturition, deficiency-heat are quenched one's thirst;
Bulbus Allii Macrostemonis return lung, stomach, large intestine channel, effect are qi-regulating the chest stuffiness relieving, activating YANG and eliminating stagnation.The thorough back of the body of main obstruction of qi in the chest and cardialgia;Chest gastral cavity ruffian;Cough
Breathe heavily abundant expectoration;Epigastric pain;Let out weight after dysentery;Leucorrhea;Furuncle carbuncle.For thoracic obstruction pain, phlegm retention cough with asthma, weight after dysentery is let out;
Fructus Lycii enters liver and kidney channel, nourishing the liver;Nourishing kidney;Lung moistening.Main caused by liver and kidney deficiency;Have a dizzy spell;Visual one is clear;Soreness of the waist and knees;Sun
The expensive essence of flaccidity;Cough due to consumptive disease;Quench one's thirst taking fluids profusely.For consumption consumptive loss, soreness of waist and knee joint, vertigo and tinnitus, Heat Diabetes, blood deficiency and yellow complexion, mesh
Dusk is not clear;
Fructus Jujubae enters spleen, stomach, tonifying the spleen and stomach;Replenishing QI and blood;Tranquilizing mind;Battalion is adjusted to defend;And the property of medicine.Main weakness of the spleen and stomach;Insufficiency of vital energy and blood;
Anorexia and loose stool;Fatigue and weakness;Palpitation and insomnia.For diarrhea due to hypofunction of the spleen, cardiopalmus, insomnia, night sweat, thrombocytopenic purpura;
Arillus Longan GUIXIN;Kidney;Liver;Spleen channel, reinforcing the heart spleen;Replenishing QI and blood;Tranquilizing mind.Main deficiency of both the heart and spleen;Caused by insufficiency of vital energy and blood
Palpitation with fear;Palpitation with a distress feeling;Insomnia;It is forgetful;Blood deficiency and yellow complexion;There is Jing uncomfortable;Metrorrhagia.For insufficiency of vital energy and blood, severe palpitation, forgetful insomnia, blood
It is empty sallow.
Compared with prior art, the invention has the advantages that:
(1) L-calcium lactate in addition macroelement, calcium citrate, calcium hydrogen phosphate, while adding in new resource food
Newborn mineral salt, newborn mineral salt be with milk surum as raw material, Jing remove the composition milk basic protein such as isolating protein, Lactose and made by profit
In the supplementary of absorption of human body, containing more mineral, mainly calcium and phosphorus, above-mentioned four kinds of material compositions are combined calcium source,
Ensure the calcium content needed for fracture repair process, and promote the absorption of calcium
(2) add the Calcium peptide of casein in protein peptide as calcium absorption enhancer, promote the absorption of calcium constituent, in food
Calcium becomes solubility calcium under gastric juice (hydrochloric acid) effect, but during in neutrality into the small intestinal of weakly alkaline environment, wherein having one
Part will be combined into insoluble calcium phosphate precipitation with phosphoric acid and cannot be absorbed by human body, when there is Calcium peptide of casein
(CCP), when, may be prevented from generating calcium phosphate precipitation, make calcium ion be constantly in dissolved state, so that fracture patient is improved to calcium
Absorbance, promote its wound healing.
(3) add the oligochitosan in new resource food, which has the absorption for improving immunity, promoting calcium and mineral.
(4) present invention addition integration of edible and medicinal herbs composition, its each component complement each other, and determined curative effect, Exocarpium Citri Rubrum, Pericarpium Citri tangerinae can increase bone
Density, not only promoting bone growing but also the broken bone effect of suppression;Herba Menthae, Bulbus Allii Macrostemonis contain infection composition;Fructus Lycii, Fructus Jujubae, Arillus Longan have
Preferable nourishing blood function;Pericarpium Citri tangerinae, Herba Menthae can nurse one's health digestive function well, and above-mentioned compatibility can effectively facilitate knitting, prevent from cutting
Mouthfeel contaminates, loses blood, and nurses one's health digestion, promotes the absorption of nutrient substance;
(5) present invention prepares powdered oil using microcapsule embedding techniqueses so that powdered oil has preferable mobility, easily
In mixing homogeneously with other powdered components;And using after microcapsule embedding techniqueses, oils and fatss are embedded in wall material, so as to avoid with
The contact of air to strengthen non-oxidizability, so as to the maximum effect of health oils and fatss can be played;
(6) present invention prepares meals elite powder using freeze drying process so that the product quality of preparation is loose, adds water
The primary characteristic of recovering dietary fiber is dissolved rapidly can;Which is prepared under vacuum state, time of contact short with oxygen, dried
Water content of materials is relatively low, is conducive to the long term storage of product;The color of meals elite is preserved to greatest extent, such as vegetable
Natural pigment keeps constant, and the loss of various aromatic substances may decrease to bottom line, and this easily increases the appetite of fracture patient, protects
Demonstrate,prove its nutritional need during curing;
(7) raw material of wound of the present invention, infection, operation and other stress state nutrient formulations is in preparation process
The previously prepared powder into 100~300 μm, this is caused when finished product is prepared, and each nutrition composition being capable of mix homogeneously, it is ensured that single
The content of each nutrition composition in the volume of position is essentially identical, while when liquid type preparation is prepared, each nutrition composition fully can divide
Dissipate and be completely dissolved into solvent, in preventing liquid, solid precipitation occur, effect of finished product product has been effectively ensured.
Specific embodiment
The present invention provide it is a kind of for fracture patient with increase bone density, infection, enrich blood, nurse one's health digestive function
Fracture tailored version clinical nutrition formula, including the component of following parts by weight:Including the component of following parts by weight:20-35 parts
Protein, 5-15 parts fat, 28-40 part carbohydrates, 3-9 part dietary fibers, 0.5-1.5 part macroelements, 0.01-0.03
Part trace element, 0.005-0.02 part fatsoluble vitamiies, 0.08-0.2 part water soluble vitamins, 0.1-1 part meals elite,
0.2-8 part integration of edible and medicinal herbs compositions, 0.5-1.2 part natural plants compounds and 0.05-0.8 part new resource foods.
With reference to embodiment, the specific embodiment of the present invention is further described.Following examples are only used for more
Plus technical scheme is clearly demonstrated, and can not be limited the scope of the invention with this.
Embodiment 1
Fracture tailored version clinical nutrition formula of the present invention includes lactalbumin powder 10.3g, soybean protein isolate
4.33g, whole milk powder 12g, dried whole-egg 0.33g, cattle colostrumss 0.16g, taurine 0.11g, ocean fish oligopeptide powder 0.266g, cheese
Calcium peptide 0.05g;Olive oil 2.77g, soybean oil 4.48g, Oleum Cocois 2.77g, perilla oil 0.64g, Medium-chain Triglycerides
0.213g;Maltodextrin 21.46g, resistant starch 13.33g;The dietary fiber selected from inulin, Rhizoma amorphophalli powder, oligomeric galactose,
At least one in oligofructose, oligomeric isomaltose, soybean polysaccharide, cyclodextrin, resistant dextrin, soybean fiber, its gross mass
For 5.99g, wherein water soluble dietary fiber 4.83g, fat-soluble dietary fiber 1.16g;Calcium 0.7g in macroelement, phosphorus 0.21g,
Potassium 0.08g, sodium 0.02g, magnesium 0.15g;Ferrum 0.011g, iodine 0.00014g, zinc 0.007g in trace element;In fatsoluble vitamin
Vitamin A 0.0006g, beta-carotene 0.000057g, vitamin D30.000001g, Vitamin E 0.009g;Water soluble vitamin
Vitamin B in raw element10.001g, vitamin B20.001g, vitamin B 60.001g, vitamin B120.000002g, dimension life
Plain C 0.117g, pantothenic acid 0.003g, Folic Acid 0.000165g, nicotinic acid 0.0165g;Oatmeal 0.333g, cucumber seed powder 0.4g;Medicine
Food with Herba Menthae 0.5g in derived components, Exocarpium Citri Rubrum 0.5g, Rhizoma Dioscoreae 0.5g, Bulbus Allii Macrostemonis 0.5g, Fructus Lycii 0.5g, Fructus Jujubae 0.5g, Arillus Longan 0.5g,
Pericarpium Citri tangerinae 0.5g;L-carnitine 1g in natural plants compound;Newborn mineral salt 0.3g, oligochitosan 0.3g in new resource food.
Embodiment 2
Fracture tailored version clinical nutrition formula of the present invention includes lactalbumin powder 10.3g, soybean protein isolate
4.33g, whole milk powder 12g, dried whole-egg 0.33g, cattle colostrumss 0.16g, taurine 0.11g, ocean fish oligopeptide powder 0.266g, cheese
Calcium peptide 0.05g;Olive oil 2.77g, soybean oil 4.48g, Oleum Cocois 2.77g, perilla oil 0.64g, Medium-chain Triglycerides
0.213g;Maltodextrin 21.46g, resistant starch 13.33g;The dietary fiber selected from inulin, Rhizoma amorphophalli powder, oligomeric galactose,
At least one in oligofructose, oligomeric isomaltose, soybean polysaccharide, cyclodextrin, resistant dextrin, soybean fiber, its gross mass
For 5.99g, water soluble dietary fiber 4.83g, fat-soluble dietary fiber 1.16g wherein in dietary fiber;Calcium in macroelement
0.6g, phosphorus 0.21g, potassium 0.08g, sodium 0.02g, magnesium 0.15g;Ferrum 0.011g, iodine 0.00014g, zinc 0.007g in trace element;
Vitamin A 0.0006g, beta-carotene 0.000057g, vitamin D in fatsoluble vitamin30.000001g, Vitamin E
0.009g;Vitamin B in water soluble vitamins10.001g, vitamin B20.001g, vitamin B 60.001g, vitamin B12
0.000002g, vitamin C 0.117g, pantothenic acid 0.003g, Folic Acid 0.000165g, nicotinic acid 0.0165g;Oatmeal 0.333g, it is yellow
Squash seed meal 0.2g;Herba Menthae 0.166g, Exocarpium Citri Rubrum 0.166g, Rhizoma Dioscoreae 0.227g, Bulbus Allii Macrostemonis 0.166g, Fructus Lycii in integration of edible and medicinal herbs composition
0.166g, Fructus Jujubae 0.166g, Arillus Longan 0.166g, Pericarpium Citri tangerinae 0.166g;L-carnitine 0.633g in natural plants compound;It is new to provide
Newborn mineral salt 0.3g, oligochitosan 0.3g in the food of source.
Embodiment 3
Fracture tailored version clinical nutrition formula of the present invention includes lactalbumin powder 10.3g, soybean protein isolate
4.33g, whole milk powder 12g, dried whole-egg 0.33g, cattle colostrumss 0.16g, taurine 0.11g, ocean fish oligopeptide powder 0.266g, cheese
Calcium peptide 0.033g;Olive oil 2.77g, soybean oil 4.48g, Oleum Cocois 2.77g, perilla oil 0.64g, Medium-chain Triglycerides
0.213g;Maltodextrin 21.46g, resistant starch 13.33g;The dietary fiber selected from inulin, Rhizoma amorphophalli powder, oligomeric galactose,
At least one in oligofructose, oligomeric isomaltose, soybean polysaccharide, cyclodextrin, resistant dextrin, soybean fiber, its gross mass
For 5.99g, water soluble dietary fiber 4.83g, fat-soluble dietary fiber 1.16g wherein in dietary fiber;Calcium in macroelement
0.6g, phosphorus 0.21g, potassium 0.08g, sodium 0.02g, magnesium 0.15g;Ferrum 0.011g, iodine 0.00014g, zinc 0.007g in trace element;
Vitamin A 0.0006g, beta-carotene 0.000057g, vitamin D in fatsoluble vitamin30.000001g, Vitamin E
0.009g;Vitamin B in water soluble vitamins10.001g, vitamin B20.001g, vitamin B 60.001g, vitamin B12
0.000002g, vitamin C 0.117g, pantothenic acid 0.003g, Folic Acid 0.000165g, nicotinic acid 0.0165g;Oatmeal 0.333g, it is yellow
Squash seed meal 0.2g;Herba Menthae 0.166g, Exocarpium Citri Rubrum 0.166g, Rhizoma Dioscoreae 0.227g, Bulbus Allii Macrostemonis 0.166g, Fructus Lycii in integration of edible and medicinal herbs composition
0.166g, Fructus Jujubae 0.166g, Arillus Longan 0.166g, Pericarpium Citri tangerinae 0.166g;L-carnitine 0.633g in natural plants compound;It is new to provide
Newborn mineral salt 0.167g, oligochitosan 0.167g in the food of source.
Embodiment 4
Fracture tailored version clinical nutrition formula of the present invention includes lactalbumin powder 10.3g, soybean protein isolate
4.33g, whole milk powder 12g, dried whole-egg 0.33g, cattle colostrumss 0.16g, taurine 0.11g, ocean fish oligopeptide powder 0.266g, cheese
Calcium peptide 0.033g;Olive oil 2.77g, soybean oil 4.48g, Oleum Cocois 2.77g, perilla oil 0.64g, Medium-chain Triglycerides
0.213g;Maltodextrin 21.46g, resistant starch 13.33g;The dietary fiber selected from inulin, Rhizoma amorphophalli powder, oligomeric galactose,
At least one in oligofructose, oligomeric isomaltose, soybean polysaccharide, cyclodextrin, resistant dextrin, soybean fiber, its gross mass
For 5.99g, water soluble dietary fiber 4.83g, fat-soluble dietary fiber 1.16g wherein in dietary fiber;Calcium in macroelement
0.3g, phosphorus 0.21g, potassium 0.08g, sodium 0.02g, magnesium 0.15g;Ferrum 0.011g, iodine 0.00014g, zinc 0.007g in trace element;
Vitamin A 0.0006g, beta-carotene 0.000057g, vitamin D in fatsoluble vitamin30.000001g, Vitamin E
0.009g;Vitamin B in water soluble vitamins10.001g, vitamin B20.001g, vitamin B 60.001g, vitamin B12
0.000002g, vitamin C 0.117g, pantothenic acid 0.003g, Folic Acid 0.000165g, nicotinic acid 0.0165g;Oatmeal 0.333g, it is yellow
Squash seed meal 0.1g;Herba Menthae 0.166g, Exocarpium Citri Rubrum 0.166g, Rhizoma Dioscoreae 0.227g, Bulbus Allii Macrostemonis 0.166g, Fructus Lycii in integration of edible and medicinal herbs composition
0.166g, Fructus Jujubae 0.166g, Arillus Longan 0.166g, Pericarpium Citri tangerinae 0.166g;L-carnitine 0.633g in natural plants compound;It is new to provide
Newborn mineral salt 0.1g, oligochitosan 0.1g in the food of source.
Embodiment 5
Fracture tailored version clinical nutrition formula of the present invention includes lactalbumin powder 10.3g, soybean protein isolate
4.33g, whole milk powder 12g, dried whole-egg 0.33g, cattle colostrumss 0.16g, taurine 0.11g, ocean fish oligopeptide powder 0.266g, cheese
Calcium peptide 0.02g;Olive oil 2.77g, soybean oil 4.48g, Oleum Cocois 2.77g, perilla oil 0.64g, Medium-chain Triglycerides
0.213g;Maltodextrin 21.46g, resistant starch 13.33g;The dietary fiber selected from inulin, Rhizoma amorphophalli powder, oligomeric galactose,
At least one in oligofructose, oligomeric isomaltose, soybean polysaccharide, cyclodextrin, resistant dextrin, soybean fiber, its gross mass
For 5.99g, water soluble dietary fiber 4.83g, fat-soluble dietary fiber 1.16g wherein in dietary fiber;Calcium in macroelement
0.3g, phosphorus 0.21g, potassium 0.08g, sodium 0.02g, magnesium 0.15g;Ferrum 0.011g, iodine 0.00014g, zinc 0.007g in trace element;
Vitamin A 0.0006g, beta-carotene 0.000057g, vitamin D in fatsoluble vitamin30.000001g, Vitamin E
0.009g;Vitamin B in water soluble vitamins10.001g, vitamin B20.001g, vitamin B 60.001g, vitamin B12
0.000002g, vitamin C 0.117g, pantothenic acid 0.003g, Folic Acid 0.000165g, nicotinic acid 0.0165g;Oatmeal 0.333g, it is yellow
Squash seed meal 0.1g;Herba Menthae 0.1g, Exocarpium Citri Rubrum 0.1g, Rhizoma Dioscoreae 0.1g, Bulbus Allii Macrostemonis 0.1g, Fructus Lycii 0.1g, Fructus Jujubae in integration of edible and medicinal herbs composition
0.1g, Arillus Longan 0.1g, Pericarpium Citri tangerinae 0.1g;L-carnitine 0.633g in natural plants compound;Newborn mineral salt in new resource food
0.1g, oligochitosan 0.1g.
Embodiment 6
Fracture tailored version clinical nutrition formula of the present invention includes lactalbumin powder 10.3g, soybean protein isolate
4.33g, whole milk powder 12g, dried whole-egg 0.33g, cattle colostrumss 0.16g, taurine 0.11g, ocean fish oligopeptide powder 0.266g, cheese
Calcium peptide 0.02g;Olive oil 2.77g, soybean oil 4.48g, Oleum Cocois 2.77g, perilla oil 0.64g, Medium-chain Triglycerides
0.213g;Maltodextrin 21.46g, resistant starch 13.33g;The dietary fiber selected from inulin, Rhizoma amorphophalli powder, oligomeric galactose,
At least one in oligofructose, oligomeric isomaltose, soybean polysaccharide, cyclodextrin, resistant dextrin, soybean fiber, its gross mass
For 5.99g, water soluble dietary fiber 4.83g, fat-soluble dietary fiber 1.16g wherein in dietary fiber;Calcium in macroelement
0.3g, phosphorus 0.21g, potassium 0.08g, sodium 0.02g, magnesium 0.15g;Ferrum 0.011g, iodine 0.00014g, zinc 0.007g in trace element;
Vitamin A 0.0006g, beta-carotene 0.000057g, vitamin D in fatsoluble vitamin30.000001g, Vitamin E
0.009g;Vitamin B in water soluble vitamins10.001g, vitamin B20.001g, vitamin B 60.001g, vitamin B12
0.000002g, vitamin C 0.117g, pantothenic acid 0.003g, Folic Acid 0.000165g, nicotinic acid 0.0165g;Oatmeal 0.333g;Medicine
Food with Herba Menthae 0.1g in derived components, Exocarpium Citri Rubrum 0.1g, Rhizoma Dioscoreae 0.1g, Bulbus Allii Macrostemonis 0.1g, Fructus Lycii 0.1g, Fructus Jujubae 0.1g, Arillus Longan 0.1g,
Pericarpium Citri tangerinae 0.1g;L-carnitine 0.633g in natural plants compound;Newborn mineral salt 0.1g, oligochitosan 0.1g in new resource food.
Embodiment 7
Fracture tailored version clinical nutrition formula of the present invention includes lactalbumin powder 10.3g, soybean protein isolate
4.33g, whole milk powder 12g, dried whole-egg 0.33g, cattle colostrumss 0.16g, taurine 0.11g, ocean fish oligopeptide powder 0.266g, cheese
Calcium peptide 0.01gg;Olive oil 2.77g, soybean oil 4.48g, Oleum Cocois 2.77g, perilla oil 0.64g, Medium-chain Triglycerides
0.213g;Maltodextrin 21.46g, resistant starch 13.33g;The dietary fiber selected from inulin, Rhizoma amorphophalli powder, oligomeric galactose,
At least one in oligofructose, oligomeric isomaltose, soybean polysaccharide, cyclodextrin, resistant dextrin, soybean fiber, its gross mass
For 5.99g, wherein water soluble dietary fiber 4.83g, fat-soluble dietary fiber 1.16g;Calcium 0.6g in macroelement, phosphorus 0.21g,
Potassium 0.08g, sodium 0.02g, magnesium 0.15g;Ferrum 0.011g, iodine 0.00014g, zinc 0.007g in trace element;In fatsoluble vitamin
Vitamin A 0.0006g, beta-carotene 0.000057g, vitamin D30.000001g, Vitamin E 0.009g;Water soluble vitamin
Vitamin B in raw element10.001g, vitamin B20.001g, vitamin B 60.001g, vitamin B120.000002g, dimension life
Plain C 0.117g, pantothenic acid 0.003g, Folic Acid 0.000165g, nicotinic acid 0.0165g;Oatmeal 0.333g;It is thin in integration of edible and medicinal herbs composition
Lotus 0.1g, Exocarpium Citri Rubrum 0.1g, Rhizoma Dioscoreae 0.05g, Bulbus Allii Macrostemonis 0.05g, Fructus Lycii 0.05g, Fructus Jujubae 0.05g, Arillus Longan 0.1g, Pericarpium Citri tangerinae 0.1g;
L-carnitine 0.633g in natural plants compound;Newborn mineral salt 0.05g, oligochitosan 0.05g in new resource food.
Embodiment 8
The preparation method of the nutritive powder of the fracture tailored version clinical nutrition formula containing embodiment 1- embodiment 7 is as follows:
1) prepare powdered oil:By the fat of predetermined weight with sucrose ester, monoglyceride, maltodextrin, water at 70 DEG C or so
Carry out mixed dissolution and prepare emulsion, the wherein consumption of sucrose ester and monoglyceride for emulsion weight 2.5%~5%, water
10~15 times for fat weight of consumption, maltodextrin consumption for emulsion weight 8%~20%;Above-mentioned emulsion is stirred
After 2~5min of mixing, 2 emulsifying homogeneous being carried out under high pressure and being processed, the emulsifying homogeneous time is 12~18min;Then sprayed
Mist is dried, and prepares powdered oil with 60~80 mesh sieves point;
2) prepare meals elite powder:The meals elite raw material of predetermined weight is cleaned up into loading vacuum lyophilization
Device, predrying is 45~55% to water content, and it is -25 DEG C~-35 that precooling to temperature is carried out to raw material in 1~1.5h then
DEG C, evacuation is carried out to vacuum freeze dryer then so as to which vacuum maintains 40~60Pa, temperature is raised and maintained
50~60 DEG C, 20h is dried, when water content is 1%~2.5%, raw material is taken out from vacuum freeze dryer, carry out crushing,
80 mesh sieves are crossed, meals elite powder is obtained;
3) integration of edible and medicinal herbs component powders are prepared:By the integration of edible and medicinal herbs composition of predetermined weight be put into pulverizer carry out crushing, mistake
60~80 mesh sieves make integration of edible and medicinal herbs component powders;
4) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, the life of fat-soluble dimension
Element, water soluble vitamins, meals elite, natural plants compound and new resource food are prepared into particle diameter respectively for 100~300
μm powdery;
5) by step 1)~step 4) obtained by powder mix homogeneously, with obtain wound, infection, operation and other should
Sharp state nutritive powder, after sterilization processing, fill is in sterilized packaging bag or is placed directly within sterilized pail pack
In.
Aforesaid operations step is both needed to carry out under the protection of noble gases, such as nitrogen protection, to prevent that powder is quick-fried
Fried danger.
Embodiment 9
The preparation method of the nutrition emulsion of the fracture tailored version clinical nutrition formula containing embodiment 1- embodiment 7 is as follows:
1) prepare powdered oil:By the fat of predetermined weight with sucrose ester, monoglyceride, maltodextrin, water at 70 DEG C or so
Carry out mixed dissolution and prepare emulsion, the wherein consumption of sucrose ester and monoglyceride for emulsion weight 2.5%~5%, water
10~15 times for fat weight of consumption, maltodextrin consumption for emulsion weight 8%~20%;Above-mentioned emulsion is stirred
After 2~5min of mixing, 2 emulsifying homogeneous being carried out under high pressure and being processed, the emulsifying homogeneous time is 12~18min;Then sprayed
Mist is dried, and prepares powdered oil with 60~80 mesh sieves point;
2) prepare meals elite powder:The meals elite raw material of predetermined weight is cleaned up into loading vacuum lyophilization
Device, predrying is 45~55% to water content, and it is -25 DEG C~-35 that precooling to temperature is carried out to raw material in 1~1.5h then
DEG C, evacuation is carried out to vacuum freeze dryer then so as to which vacuum maintains 40~60Pa, temperature is raised and maintained
50~60 DEG C, 20h is dried, when water content is 1%~2.5%, raw material is taken out from vacuum freeze dryer, carry out crushing,
80 mesh sieves are crossed, meals elite powder is obtained;
3) integration of edible and medicinal herbs component powders are prepared:By the integration of edible and medicinal herbs composition of predetermined weight be put into pulverizer carry out crushing, mistake
60~80 mesh sieves make integration of edible and medicinal herbs component powders;
4) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, the life of fat-soluble dimension
Element, water soluble vitamins, natural plants compound and new resource food are prepared into the powdery that particle diameter is 100~300 μm respectively;
5) by step 4) in protein powder be dissolved in temperature be 20~25 DEG C, abundant water in the pure water of 280~350g
Change 3~15h, obtain in protein aqueous solution, then by step 4) in carbohydrate powder, macroelement powder, micro unit
Plain powder, water soluble vitamins powder are dissolved in protein aqueous solution, carry out gentle agitation, and the water being uniformly mixed mixes
Liquid;
6) by step 1) in microcapsule embedding treatment after fat powder, step 2) in prepare meals elite powder, step
It is rapid 3) in prepare integration of edible and medicinal herbs component powders, step 4) in prepare fatsoluble vitamin powder and natural plants compound powder
End sequentially adds step 5) in gained aqueous phase solution, and carry out strong agitation, addition emulsifying agent and thickening agent obtain mixing equal
Even concentrated emulsions;
7) in step 6) described in concentrated emulsions in add 20~25 DEG C, the pure water of 100~170g stir, while going
The foam of skim-coat, obtains Emulsion, then by Emulsion under 300~600Bar homogenizing, homogenisation cycle number of times be 2-5 time, then
Sterilize at 110~130 DEG C, be cooled to room temperature, nutrition emulsion is obtained, and by nutrition emulsion fill in sterilized packaging bag
In.
Aforesaid operations step is both needed to carry out under the protection of noble gases, such as nitrogen protection, to prevent that powder is quick-fried
Fried danger.
Fracture experiment
1~embodiment of embodiment 7 is respectively taken into 300g, 75% ethanol solution 750ml, heating and refluxing extraction is separately added into
1.5h, cooling, filtration collect filtrate, and insoluble matter repeats above extraction process 3 times.Merging filtrate, is sloughed on a rotary evaporator
Solvent.Each extract is separately added into α-MEM culture medium 20ml, adds micro twen-80 hydrotropy, filtration sterilization, is configured to containing carrying
Take the α-MEM culture medium (1~embodiment of embodiment 7) of thing.
The SD neonatal rats 8 of birth 4d are chosen, and at anesthesia Cervical vertebra dislocation, after death 10min are soaked with 75% ethanol,
Peel off under aseptic condition and take out parietal bone, when dissected retains the cerebral dura mater of its outer surface periosteum and inner surface.Rushed with α-MEM culture fluid
After washing 3 times, be put into containing 15% hyclone, 20mmol/L HEPES, 1000U/ml penicillins, 1000mg/L streptomycins α-
In the culture dish of MEM culture medium, each parietal bone is pruned and is divided into 4 pieces.Osteocomma is put in 24 well culture plates, 7 are randomly divided into
The individual experimental group containing osteocomma and 1 blank group without osteocomma, per group contains 4 osteocommas, is separately added into containing 10% tire cattle per hole
Serum, 20mmol/L HEPES, 100U/ml penicillins, α-MEM culture medium 2ml of 100mg/L streptomycins, in 37 DEG C, 5%CO2
24h is cultivated in incubator.Second day changes liquid, adds α-MEM culture medium 2ml (blank group adds α-MEM culture medium) containing extract,
Cultivate 1 respectively according to different time, 3,7,10d, liquid 1 time is changed per 3d.
Calcium ion concentration is detected:Culture supernatant 0.5ml is collected respectively, after diluting 20 times with the ultra-pure water of resistance 18M Ω,
Total calcium content is determined with atomic absorption spectrophotometer, and is subtracted each other with culture medium calcium ion concentration in the blank group without osteocomma,
(* is represented and significant difference, P is compared with blank group to calculate the changing value of calcium ion concentration<0.05;* is represented and is compared with blank group
Significant difference, P<0.01), as a result as shown in table 1.
Impact (n=4) of the 1 each embodiment of table to culture medium calcium ion concentration change in bone incubation
Shown by upper table result, respectively after culture 1,3,7,10d, and blank group contrast, 1~embodiment of embodiment, 7 tissue culture
Foster base calcium ion concentration variable quantity has significant change, and wherein embodiment 1 cultivates 7 days (P<0.05), 10 days (P<0.01) it is, and real
Apply 2 tissue culture of example and support 10 days (P<0.05), significant difference.Illustrate that 1~embodiment of embodiment 7 can promote osteoblast, increase to calcium
The absorption of ion, accelerates bone repair.
Suppress osteoclast detection:After culture 10d, parietal bone is taken out, with the 4 DEG C of fixations of 95% ethanol and 5% glacial acetic acid
10min.After PBS rinses 3 times, osteocomma is immersed into (six azo paramagenta 1ml, 0.2mom/L acetate buffer solutions in stain incubation liquid
18ml, naphthols AS-BI phosphate 20mg, tartrate 50mmol), 37 DEG C of lucifuges incubation 30min, distilled water flushing 3 times, immediately
Resinenes sealing, light Microscopic observation is used simultaneously to count red or mauve tartaric-resistant positive cell.
After 2 each embodiment 10d of table, Mus parietal bone Tartrate resistant acid phosphatase positive cell compares (n=4)
Tartrate resistant acid phosphatase positive staining is the characteristic mark of osteoclast, as seen from the above table, and blank group
Compare, the Tartrate resistant acid phosphatase positive cell of each embodiment experiment has certain reduction, and wherein 1 group of reduction of embodiment shows
Write (P<0.05).Illustrate that 1~embodiment of embodiment 7 can suppress osteoclast, reduce the differentiation of osteoclast or accelerate its apoptosis,
Reduce bone resorption.
As bone metabolism process is the collective effect of osteoblast and osteoclast, above experiment further illustrates embodiment
1~embodiment 7 can act on osteoblast, can act on osteoclast again, accelerate bone repair.
From above-described embodiment, in fracture tailored version clinical nutrition formula of the present invention, various components mutually match
Close, more reasonable, comprehensive nutritional support is provided for tumor patient, while add and increasing bone density, infection, enriching blood, nurse one's health
The integration of edible and medicinal herbs composition of digestion, natural plants compound and new resource food, contribute to knitting, the reinforcement of fracture patient
Matter, improves therapeutic effect;Can be shown that the fracture tailored version clinical nutrition of present invention preparation is matched somebody with somebody and can be promoted into by above-mentioned experiment
Osteocyte, increases absorption to calcium ion, accelerates bone repair, while suppress osteoclast, reduce osteoclast differentiation or
Accelerate its apoptosis, reduce bone resorption.
Above the specific embodiment of the present invention is described in detail, but which has been only used as example, the present invention has been not intended to limit
In particular embodiments described above.To those skilled in the art, any equivalent modifications carried out by the practicality and replace
In generation, is also all among scope of the invention.Therefore, the equalization made without departing from the spirit and scope of the invention is converted and is repaiied
Change, should all cover within the scope of the invention.
Claims (8)
1. a kind of fracture tailored version clinical nutrition formula, it is characterised in that including the component of following parts by weight:20-35 part eggs
White matter, 5-15 parts fat, 28-40 part carbohydrates, 3-9 part dietary fibers, 0.5-1.5 part macroelements, 0.01-0.03 parts
Trace element, 0.005-0.02 part fatsoluble vitamiies, 0.08-0.2 part water soluble vitamins, 0.1-1 part meals elite, 0.2-
8 parts of integration of edible and medicinal herbs compositions, 0.5-1.2 part natural plants compounds and 0.05-0.8 part new resource foods;
Wherein, the integration of edible and medicinal herbs composition selected from Herba Menthae, Exocarpium Citri Rubrum, Rhizoma Dioscoreae, Bulbus Allii Macrostemonis, Fructus Lycii, Fructus Jujubae, Arillus Longan, in Pericarpium Citri tangerinae extremely
Few one kind;
Wherein, the new resource food selected from first milk basic protein, γ-aminobutyric acid, oligochitosan, eucommia Bark male flower, Folium Bambosae flavone,
At least one in phosphopeptide caseinate, avenabeta glucosan, newborn mineral salt, yeast beta-dextran, leaf of Moringa, oligomeric xylose.
2. a kind of fracture tailored version clinical nutrition formula according to claim 1, it is characterised in that the integration of edible and medicinal herbs into
In point, the parts by weight of each component are as follows:Herba Menthae 0-0.2 parts, Exocarpium Citri Rubrum 0-0.2 part, Rhizoma Dioscoreae 0-0.25 parts, Bulbus Allii Macrostemonis 0-0.2 parts, Chinese holly
Qi 0-0.2 part, Fructus Jujubae 0-0.2 parts, Arillus Longan 0-0.2 parts, Pericarpium Citri tangerinae 0-0.2 parts.
3. a kind of fracture tailored version clinical nutrition formula according to claim 1, it is characterised in that in the protein
Protein peptide is selected from soybean oligopeptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide powder, laughable peptide, amino peptide, the white of an egg
At least one in protein peptide, Calcium peptide of casein.
4. a kind of fracture tailored version clinical nutrition formula according to claim 1, it is characterised in that the natural plants
Compound is selected from L-carnitine, glucosamine, oligofructose, phylloxanthin, plant sterol, lycopene, resveratrol, garlicin
In at least one.
5. a kind of fracture tailored version clinical nutrition formula according to claim 1, it is characterised in that the protein and ammonia
The high quality protein weight provided in base acid accounts for more than the 70% of gross protein weight.
6. a kind of fracture tailored version clinical nutrition formula according to claim 1, it is characterised in that n-6 in the fat
The ratio of fatty acid and n-3 fatty acids is 3~4:1.
7. it is a kind of it is as claimed in claim 1 fracture tailored version clinical nutrition formula preparation method, it is characterised in that the fat
Fat makes powder using microcapsule embedding techniqueses, and the meals elite makes powder, the medicine food using freeze drying process
With derived components by crushing, sieving and make powder.
8. preparation method according to claim 7, it is characterised in that the mesh number that the integration of edible and medicinal herbs composition sieves is 60-
80 mesh.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611206868.2A CN106579460A (en) | 2016-12-23 | 2016-12-23 | Special clinical nutrition formula for fracture and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611206868.2A CN106579460A (en) | 2016-12-23 | 2016-12-23 | Special clinical nutrition formula for fracture and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106579460A true CN106579460A (en) | 2017-04-26 |
Family
ID=58601026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611206868.2A Pending CN106579460A (en) | 2016-12-23 | 2016-12-23 | Special clinical nutrition formula for fracture and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106579460A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107212250A (en) * | 2017-05-17 | 2017-09-29 | 柳州市北部科技服务有限公司 | A kind of clinic dietary food and preparation method thereof |
CN107242550A (en) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
CN107319524A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
CN107440102A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
CN107596012A (en) * | 2017-09-25 | 2018-01-19 | 宁国平衡健康管理有限公司 | It is a kind of to be used to treat pill of fracture and its preparation method and application |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN108013453A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof |
CN109601923A (en) * | 2018-08-10 | 2019-04-12 | 丽睿客信息科技(北京)有限公司 | Nutraceutical with calcium-enriching function |
CN114947138A (en) * | 2022-05-25 | 2022-08-30 | 河南磐康健康管理股份有限公司 | Milk calcium composition for preventing and improving calcium deficiency disease, and preparation method and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103463380A (en) * | 2013-09-24 | 2013-12-25 | 孙丽娟 | Traditional Chinese medicine preparation for treating fracture and preparation method thereof |
CN104207144A (en) * | 2014-09-26 | 2014-12-17 | 上海励成营养产品科技股份有限公司 | High-energy enteral nutrition multi polymerizer |
CN104256595A (en) * | 2014-09-26 | 2015-01-07 | 上海励成营养产品科技股份有限公司 | Intacted protein enteral nutrition multi-polymerization agent |
CN104286849A (en) * | 2014-09-26 | 2015-01-21 | 上海励成营养产品科技股份有限公司 | Diabetes-specific enteral nutrition multi-polymerization agent |
CN104855997A (en) * | 2015-04-23 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-whole nutrient formula food for osteoporosis |
-
2016
- 2016-12-23 CN CN201611206868.2A patent/CN106579460A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103463380A (en) * | 2013-09-24 | 2013-12-25 | 孙丽娟 | Traditional Chinese medicine preparation for treating fracture and preparation method thereof |
CN104207144A (en) * | 2014-09-26 | 2014-12-17 | 上海励成营养产品科技股份有限公司 | High-energy enteral nutrition multi polymerizer |
CN104256595A (en) * | 2014-09-26 | 2015-01-07 | 上海励成营养产品科技股份有限公司 | Intacted protein enteral nutrition multi-polymerization agent |
CN104286849A (en) * | 2014-09-26 | 2015-01-21 | 上海励成营养产品科技股份有限公司 | Diabetes-specific enteral nutrition multi-polymerization agent |
CN104855997A (en) * | 2015-04-23 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-whole nutrient formula food for osteoporosis |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107212250A (en) * | 2017-05-17 | 2017-09-29 | 柳州市北部科技服务有限公司 | A kind of clinic dietary food and preparation method thereof |
CN107242550A (en) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
CN107319524A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
CN107440102A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN107596012A (en) * | 2017-09-25 | 2018-01-19 | 宁国平衡健康管理有限公司 | It is a kind of to be used to treat pill of fracture and its preparation method and application |
CN108013453A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof |
CN109601923A (en) * | 2018-08-10 | 2019-04-12 | 丽睿客信息科技(北京)有限公司 | Nutraceutical with calcium-enriching function |
CN114947138A (en) * | 2022-05-25 | 2022-08-30 | 河南磐康健康管理股份有限公司 | Milk calcium composition for preventing and improving calcium deficiency disease, and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106579460A (en) | Special clinical nutrition formula for fracture and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN103947888B (en) | A kind of for lamb feed improving meat flavor and preparation method thereof | |
CN107242550A (en) | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
CN106942748A (en) | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN106578093A (en) | Wound, infection, operation and other stress state special-purpose clinical nutrition formula and preparation method thereof | |
CN104922550A (en) | Traditional Chinese medicine combination and application thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN101816425B (en) | Powder mixture of whole American ginseng/giant salamander and preparation method thereof | |
CN106306533A (en) | Traditional Chinese medicine feed for preventing and treating infectious bronchitis and preparation method thereof | |
CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
CN1939520A (en) | Yizhi capsule for improving memory and its production | |
CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
CN105230891A (en) | Ginseng, orange peel and poria cocos tea beverage and preparation method thereof | |
CN104479964A (en) | Hibiscus esculentus-fungus-algae health wine and preparation method thereof | |
CN105727253A (en) | Composition for protecting liver, clearing away toxic materials, preventing and treating liver and related metabolic diseases and preparation method thereof | |
CN110403112A (en) | A kind of preparation method of bubble orange juice | |
CN104839704A (en) | Yang invigorating non-total nutrient formula food | |
CN106036894B (en) | A kind of food compositions for improving chemotherapy symptom and preparation method thereof | |
CN101804018A (en) | Traditional Chinese medicine mask powder with chloasma removing function and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170426 |
|
RJ01 | Rejection of invention patent application after publication |